In a nutshell This study investigated the effectiveness of cetuximab (Erbitux) combined with FOLFOX-4 (leucovorin, fluorouracil, and oxaliplatin) chemotherapy to treat metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that this treatment is associated with improved cancer outcomes. Some background...
Read More
In a nutshell This study investigated the safety of the chemotherapies mFOLFOX6 and XELOX in Japanese colon cancer patients. Researchers suggested that the safety of both treatments is acceptable. Some background FOLFOX chemotherapy is the standard treatment for stage 3 colon cancer patients who underwent surgery. mFOLFOX6 combines leucovorin,...
Read More
In a nutshell This study investigated how oxaliplatin chemotherapy causes liver damage. The authors provided insight into the mechanism of liver injury, and suggest that bevacizumab (Avastin) may protect against such injury. Some background Oxaliplatin is a chemotherapeutic drug which is commonly used to treat advanced colorectal cancer (CRC)....
Read More
In a nutshell This study looked at the side effects of one chemotherapy regime in colon cancer patients over the age of 70. Some background Surgery is the standard treatment for stage III colon cancer (cancer that has spread beyond the colon to the lymph nodes), while chemotherapy is also effective. A combination of a type of...
Read More
